CClinicalTrials.gg
CompletedNCT05218967Updated Feb 22, 2024

Virtual Reality in Laryngology

An interventional study of Virtual Reality Headset in Pain Management During Office Laryngeal Procedures, sponsored by Weill Medical College of Cornell University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-22.

Sponsored by Weill Medical College of Cornell University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to compare patient's pain and anxiety undergoing laryngeal procedures and esophageal manometry while wearing a VR headset to standard of care. It is hypothesized that patient's using the VR headset during the procedure will have reduced pain and anxiety as compared to their standard of care counterparts because the VR environment will distract them from their procedure.

Read the detailed description

This is a prospective randomized controlled trial, comparing patients' pain and anxiety experience while wearing a VR headset and receiving standard analgesia during In-office aerodigestive procedures (IOAEP) to patients' experience receiving standard analgesia only during IOAEP.

02

Conditions studied

  • Pain Management During Office Laryngeal Procedures
03

In context

Lead sponsor

Weill Medical College of Cornell University is the lead sponsor of 867 studies on the registry; 160 are open to participants now.

Of its 119 completed or terminated interventional studies of FDA-regulated products, 91 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adult patients (18 or older)
  • Patients scheduled for IOAEP, including laryngeal biopsies, percutaneous injection laryngoplasty, KTP ablation of hemorrhagic polyps and respiratory papilloma, and transnasal esophagoscopy (TNE), and esophageal manometry.

Exclusion criteria

Exclusion Criteria:

  • Patients under 18 years of age
  • Patients unable to consent
  • Non-English-speaking patients
  • Patients who have undergone prior IOAEP
  • Patients who have used any psychotropic or analgesic medication within the last 24 hours due to the possible confounding effect on pain or anxiety perception
  • Patients with motion sickness or uncorrected visual impairment (legal blindness)
  • Patients with past medical history of seizures or visual abnormalities
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    In-office procedure with VR-assistance

    Other: Virtual Reality Headset

  • No intervention
    In-office procedure without VR-assistance

Interventions

  • OtherVirtual Reality Headset

    A head-worn apparatus that completely covers the eyes for an immersive 3D experience. The VR headset will be worn during the procedure.

06

What researchers measure

Primary outcomes

  1. Pain during procedure, as measured by the McGill Pain Questionnaire

    individually rated pain descriptors with 11 addressing sensory pain and 4 focusing on affective components of pain. Each item is rated on a 4-point scale that ranges from none to severe.

    Time frame: During Procedure

  2. Anxiety during the procedure , as measured by the spielberger State-Trait Anxiety Inventory (SF- STAI)

    The STAI consists of 6 questions concerning patient's current state of anxiety with responses ranging from (1) never to almost always (4).

    Time frame: During Procedure

  3. Post Procedure Patient Questionnaire

    Patients will be asked if they would repeat the procedure again on a scale of 1-5 with 1 being never and 5 being always.

    Time frame: Immediately After Procedure

  4. Physician Questionnaire

    Clinicians will fill out a short 6 question survey about the use of VR during their procedure. The survey is a short 6 item questionnaire inquiring about difficulty and success of the procedure, perceived patients' discomfort, observed patient agitation, interference and benefit of the VR headset. These questions will be answered using a Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree).

    Time frame: Immediately After Procedure

  5. Heart rate

    Heart rate will will be measured through AD instruments PowerLab.

    Time frame: Measures will be recorded immediately before and immediately after the procedure.

  6. Temperature

    Temperature will be measured through AD instruments PowerLab

    Time frame: Measures will be recorded immediately before and immediately after the procedure.

  7. Galvanic Skin Activity

    Galvanic Skin Activity will be measured through AD instruments PowerLab

    Time frame: Measures will be recorded immediately before and immediately after the procedure.

  8. Pain as measured by the Visual Analog Scale

    Visual Analog Pain Scale measured pain on range from 0-100 (0 is no pain and 100 is max pain) about time of pain, unpleasantness, average pain, and worst pain on a scale of 0-100.

    Time frame: Measures will be recorded immediately after the procedure.

  9. Upper Esophageal Sphincter Pressure

    Upper Esophageal Sphincter Pressure will be measured through the probe inserted during the High Resolution Manometry

    Time frame: During the Procedure

07

Study locations

1 site
  • Weill Cornell Medicine
    New York, New York 10021, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05218967
Lead sponsor
Weill Medical College of Cornell University
Responsible party
Sponsor
First posted
Feb 1, 2022
Start date
Feb 14, 2022
Primary completion
Aug 8, 2022
Completion
Aug 8, 2022
Last update
Feb 22, 2024

Study contacts

Anais Rameau, M.D.
principal investigator · Weill Medical College of Cornell University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion